JP MORGAN/CALL/ABBOTT LABORATORIES/165/0.1/20.06.25 Share Price

Warrant

DE000JK39U99

Market Closed - Börse Stuttgart 07:40:41 09/05/2024 BST
0.023 EUR -14.81% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/165/0.1/20.06.25
Current month-36.11%
1 month-63.49%
Date Price Change Volume
09/05/24 0.023 -14.81% 0
08/05/24 0.027 +8.00% 0
07/05/24 0.025 -10.71% 0
06/05/24 0.028 0.00% 0
03/05/24 0.028 -12.50% 0

Delayed Quote Börse Stuttgart

Last update May 09, 2024 at 07:40 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK39U9
ISINDE000JK39U99
Date issued 19/03/2024
Strike 165 $
Maturity 20/06/2025 (407 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.099
Lowest since issue 0.023
Spread 0.06
Spread %72.29%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.9 USD
Average target price
126.1 USD
Spread / Average Target
+20.20%
Consensus